Next Science
About:
Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.
Website: https://www.nextscience.com/
Twitter/X: nextscience
Description:
Next Science provides commercialising and developing its Xbio technology, which is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria, in a range of products for the treatment of biofilm based infections.
Total Funding Amount:
$15.8M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Chatswood, New South Wales, Australia
Founded Date:
2012-01-01
Contact Email:
info(AT)nextscience.com
Founders:
Matthew Myntti
Number of Employees:
11-50
Last Funding Date:
2023-09-25
IPO Status:
Public
Industries:
© 2025 bioDAO.ai